Molecular interplay of insulin resistance and cancer: advances in monoclonal antibody therapeutics.

Moni SS, Ayish F, Musawi S, Salawi A, Elmobark ME, Jabeen A, Mohammed MAA, Aqdi MJ, Aziabi MY, Harbi RH, Ghazwani AAM, Almalki SH, Abdullah Sharif R, Ezzi HM, Suwaydi HM, E Alajam T, Awaji SA, Nammazi AYM, Maashi AM, Faqiri NI, Dohal ASA, Burayk NS

Open source

DOI: 10.1080/15384047.2026.2708386
Published: 2026 Dec 31
Container: Cancer biology & therapy
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/15384047.2026.2708386,
  title = {Molecular interplay of insulin resistance and cancer: advances in monoclonal antibody therapeutics.},
  author = {Moni SS and Ayish F and Musawi S and Salawi A and Elmobark ME and Jabeen A and Mohammed MAA and Aqdi MJ and Aziabi MY and Harbi RH and Ghazwani AAM and Almalki SH and Abdullah Sharif R and Ezzi HM and Suwaydi HM and E Alajam T and Awaji SA and Nammazi AYM and Maashi AM and Faqiri NI and Dohal ASA and Burayk NS},
  year = {2026},
  journal = {Cancer biology \& therapy},
  doi = {10.1080/15384047.2026.2708386},
  url = {https://doi.org/10.1080/15384047.2026.2708386}
}

RIS

TY  - JOUR
TI  - Molecular interplay of insulin resistance and cancer: advances in monoclonal antibody therapeutics.
AU  - Moni SS
AU  - Ayish F
AU  - Musawi S
AU  - Salawi A
AU  - Elmobark ME
AU  - Jabeen A
AU  - Mohammed MAA
AU  - Aqdi MJ
AU  - Aziabi MY
AU  - Harbi RH
AU  - Ghazwani AAM
AU  - Almalki SH
AU  - Abdullah Sharif R
AU  - Ezzi HM
AU  - Suwaydi HM
AU  - E Alajam T
AU  - Awaji SA
AU  - Nammazi AYM
AU  - Maashi AM
AU  - Faqiri NI
AU  - Dohal ASA
AU  - Burayk NS
PY  - 2026
JO  - Cancer biology & therapy
DO  - 10.1080/15384047.2026.2708386
UR  - https://doi.org/10.1080/15384047.2026.2708386
ER  -

APA

SS, M., F, A., S, M., A, S., ME, E., A, J., MAA, M., MJ, A., MY, A., RH, H., AAM, G., SH, A., R, A. S., HM, E., HM, S., T, E. A., SA, A., AYM, N., AM, M., NI, F., ASA, D., & NS, B. (2026). Molecular interplay of insulin resistance and cancer: advances in monoclonal antibody therapeutics.. Cancer biology & therapy. https://doi.org/10.1080/15384047.2026.2708386

Source records

pubmed · retrieved 2026-09-26T21:23:16.134Z